Clinical research in HIV, HCV coinfection
HIV, HIV/HCV coinfection
Lo Re V 3rd, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R.
: Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
AIDS Behav. 17(1): 94-103, Jan 2013.
Amorosa VK, Aibana O, Shire N, Dorey-Stein Z, Ferrara T, Gilmore J, Kostman J, Lo Re V: Willingness to Undergo a Repeat Liver Biopsy among HIV/Hepatitis C Virus-Coinfected and Hepatitis C Virus-Monoinfected Patients. Journal of Clinical Gastroenterology. ]
(eds.). Epub, Jan 2013.
Lee YJ, Osinusi A, M Kang, T Umbleja, Amorosa VK, Kottilil S, Peters MG: Augmentation of Interferon signaling by Nitazoxanide in HIV HCV Coinfected Patients : Exploratory Analysis from the ACTG5269 trial.
Conference on Retroviruses and Opportunistic Infections, March 2013, Atlanta GA. 2013.
Raphael BA, Dorey-Stein ZL, Lott J, Amorosa V, Lo Re V 3rd, Kovarik C.
: Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection.
J Am Acad Dermatol. Epub ahead of print, February 2012
Nagler A, Kim B, Gormley R, Chandler L, Han J, Amorosa V, Kovarik C.: A Verrucous Nodule on the Upper Lip: A Case of Coccidioidomycosis in a Non-endemic Region. Cutis in press, 2012.
Amorosa V, Umbleja T, Johnson V, Kang M, Leutkemeyer A, Bardin M, Haas D, Chung R, Yesmin S, Alston-Smith B, Tebas P, Peters M
: The addition of Nitazoxanide to peginterferon alfa-2a and ribavirin does not significantly improve sustained virologic response in HCV treatment-naïve genotype 1 HIV-1/HCV co-infected subjects: Results of ACTG 5269. IAS conference, Washington, July 2012 2012.
Lo Re V, Teal V, Localio R, Amorosa V, Kaplan D, Gross R: Adherence to Hepatitis C Virus Therapy in HIV-Infected Patients
Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q142, 2012 Notes: Poster presentation.
Hafkin J, Osborn M, Kostman J, Chang KM, Amorosa V, Localio R, Mounzer K, Gross R, Lo Re V. : Incidence and Risk Factors for Incomplete HBV Suppression Among Tenofovir-Treated HIV/HBV-Coinfected Patients Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q-173, 2012 Notes: Poster presentation.
Luetkemeyer A, Umbleja T, Amorosa V, Dayyeh B, Chung RT, Kang M, Bardin M, Haas DW, Tebas P, Peters M: Nitazoxanide (NTZ) may Mitigate the Unfavorable Association between IL28B Genotype and Hepatitis C Virus (HCV) Treatment Response to Pegylated Interferon-based therapy
Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q-143, 2012 Notes: Poster presentation.
Lemonovich T, Hanes K, Lautenbach E, Amorosa V: Combination Therapy with an Aminoglycoside for Staphylococcus aureus Endocarditis and/or Persistent Bacteremia Is Associated with Decreased Rate of Recurrent Bacteremia: a Cohort Study. Infection 39(6): 549-54, December 2011 Notes: Epub 2011 Sep 6.
back to top
Last updated: 06/26/2013
The Trustees of the University of Pennsylvania